|1.||Lidar, Merav: 2 articles (11/2012 - 07/2007)|
|2.||Shtrasburg, Shmuel: 2 articles (11/2012 - 07/2007)|
|3.||Livneh, Avi: 2 articles (11/2012 - 07/2007)|
|4.||Pras, Mordechai: 2 articles (11/2012 - 07/2007)|
|5.||Gal, Rivka: 2 articles (11/2012 - 07/2007)|
|6.||Nyström, Sofia N: 2 articles (09/2012 - 01/2008)|
|7.||Westermark, Gunilla T: 2 articles (09/2012 - 01/2008)|
|8.||Ueda, Mitsuharu: 2 articles (10/2010 - 11/2006)|
|9.||Ando, Yukio: 2 articles (10/2010 - 11/2006)|
|10.||Sun, Xuguo: 2 articles (10/2010 - 11/2006)|
03/01/2008 - "Studies of amyloid enhancing factor (AEF)-induced amyloidosis are commonly performed in mice. "
06/01/2007 - "Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis."
03/01/2014 - "AA amyloidosis was induced by injection of amyloid enhancing factor (AEF) in huIL-6 transgenic mice. "
11/01/2012 - "AA amyloidosis was induced in Swiss male mice using amyloid enhancing factor and AgNO(3). "
10/01/2010 - "It is well known that, similar to an infectious prion protein, amyloid-enhancing factor (AEF) acts as a transmissible agent in AA amyloidosis. "
07/01/1999 - "Although amyloid-enhancing factor is not required, its addition to culture medium results in larger and more numerous amyloid deposits. "
03/28/1995 - "Preincubation of amyloid enhancing factor with IDOX significantly reduced the formation of amyloid deposits. "
10/01/1997 - "Moreover, amyloid deposition in apoE-deficient mice as well as C57BL/6J control mice started 48 or 72 hours after injection of amyloid-enhancing factor and silver nitrate, although the amount of amyloid deposit in C57BL/6J control mice was slightly larger than that in apoE-deficient mice. "
02/01/1994 - "Previous studies into the nature of the relationship between ubiquitin (UB), possessing intrinsic amyloid enhancing factor (AEF) activity; serum amyloid A (SAA), the precursor protein of AA amyloid; and activated monocytoid cells have indicated a temporal and spatial relationship between these proteins and tissue AA amyloid deposits. "
10/01/1997 - "Hepatic mRNA levels of the negative APR apolipoprotein A-I (apo A-I) and serum albumin were down-regulated by silver nitrate treatment; rmIL-1ra partially restored serum albumin mRNA levels but not those of apo A-I. The IL-1ra-mediated reduction in inflammation-induced hepatic mRNA and serum protein concentrations of A-SAA and SAP (the precursors of the main protein components of amyloid deposits in secondary amyloidosis) was, however, not sufficient to prevent or delay early amyloid deposition in the silver nitrate/amyloid enhancing factor model of accelerated amyloidosis. "
01/01/2005 - "Amyloid-enhancing factor (AEF) is a biological "activity" that is defined in the context of inflammation-associated amyloidogenesis (AA). "
03/01/1985 - "Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation."
06/01/1999 - "Amyloid enhancing factor (AEF) is an activity that appears naturally during the course of persistent inflammation and precedes, by 24-48 h, AA amyloid deposition in appropriate murine models. "
12/01/1987 - "Administration of amyloid enhancing factor alters experimental inflammation to bring about accelerated deposition of amyloid A fibrils first in spleen and later in other organs. "
09/01/2011 - "Amyloidosis was induced by amyloid-enhancing factor and silver nitrate injection; ASO treatment was initiated 1 week later and continued 1× or 3× per week; inflammation was re-triggered by subsequent injection(s) of silver nitrate; mice were sacrificed after 4-5 weeks. "
|4.||Echinococcosis (Hydatid Cysts)
10/01/1989 - "Echinococcus multilocularis: characterization of an alveolar hydatid cyst-induced amyloid enhancing factor."
02/01/1988 - "Induction of amyloid enhancing factor and its biological properties in murine alveolar hydatidosis."
02/01/1988 - "The biological activity and time of appearance of alveolar hydatid cyst induced splenic amyloid enhancing factor (AEF) with respect to amyloid deposition in the spleens were determined in C57BL/6J mice. "
02/01/1988 - "Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors."
10/01/1988 - "Low ionic strength acidic buffer, Sephadex G-200 and Benzamidine-Sepharose (BZ) gel chromatography, have been used for the partial purification of alveolar hydatid cyst (AHC) induced amyloid enhancing factor (AEF). "
|5.||Alzheimer Disease (Alzheimer's Disease)
01/01/1991 - "Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis."
01/01/1988 - "Soluble brain extracts containing 0.1 to 16 mg of protein from 3 normal human brain and 11 patients with Alzheimer's disease, Down's syndrome and other neurological disorders were assayed for amyloid enhancing factor (AEF) activity in the mouse bioassay. "
05/11/1992 - "Tris-HCl or Laemmli sample buffer extracted frontal lobe and hippocampal samples from normal aged and Alzheimer's disease (AD) subjects were used to determine total ubiquitin (Ub), distribution of monomeric Ub and Ub-protein conjugates and amyloid enhancing factor (AEF) activity using the dot-blot, Western blot and mouse AEF bioassay techniques, respectively. "
|1.||Amyloid (Amyloid Fibrils)
|3.||Serum Amyloid A Protein (Serum Amyloid A)
|5.||Proteins (Proteins, Gene)
|8.||allogenic effect factor (AEF)
|9.||Messenger RNA (mRNA)
|10.||Collagen Type IV (Type IV Collagen)